Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Weitz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Disease in Childhood|July 20, 2016
Dying later, surviving longerDominic Wilkinson, James Weitz
The Lancet. Rheumatology|October 21, 2020
The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLHAkhila Kavirayani, James E G Charlesworth, Shelley Segal, et al.
Pediatric Blood & Cancer|June 11, 2021
Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill childrenJames E G Charlesworth, Shaun Wilson, Amrana Qureshi, et al.
Neurocritical Care|June 3, 2025
KidsBrainIT: Visualization of the Impact of Cerebral Perfusion Pressure Insult Intensity and Duration on Childhood Brain Trauma OutcomeBavo Kempen, Bart Depreitere, Ian Piper, et al.
The Lancet. Respiratory Medicine|March 24, 2026
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trialMalcolm G Semple, Chloe Donohue, Laura Price, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Disease in Childhood|July 20, 2016
Dying later, surviving longerDominic Wilkinson, James Weitz
The Lancet. Rheumatology|October 21, 2020
The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLHAkhila Kavirayani, James E G Charlesworth, Shelley Segal, et al.
Pediatric Blood & Cancer|June 11, 2021
Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill childrenJames E G Charlesworth, Shaun Wilson, Amrana Qureshi, et al.
Neurocritical Care|June 3, 2025
KidsBrainIT: Visualization of the Impact of Cerebral Perfusion Pressure Insult Intensity and Duration on Childhood Brain Trauma OutcomeBavo Kempen, Bart Depreitere, Ian Piper, et al.
The Lancet. Respiratory Medicine|March 24, 2026
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trialMalcolm G Semple, Chloe Donohue, Laura Price, et al.
Pageof 1